Back
Marathon Petroleum Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
62
MPC
Marathon Petroleum
Last Price:
158.29
Seasonality Move:
9.23%
Sell
50
ALNY
Alnylam Pharmaceuticals
Last Price:
296.68
Seasonality Move:
13.14%
Buy
62
Marathon Petroleum (MPC)
is a Buy
Is Marathon Petroleum a Buy, Sell or Hold?
- The current Marathon Petroleum [MPC] share price is $158.24. The Score for MPC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- MPC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $296.48. The Score for ALNY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MPC Stock Price Chart
What is Marathon Petroleum's stock price today?
-
The Marathon Petroleum share price today is $158.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MPC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $296.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MPC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.37 | Sell |
| Relative Strength Index (14 RSI): | 41.95 | Sell |
| Chaikin Money Flow: | 1104234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (159.15 - 168.17) | Sell |
| Bollinger Bands (100): | (163.27 - 174.99) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.23 | Buy |
| Relative Strength Index (14 RSI): | 66.96 | Buy |
| Chaikin Money Flow: | 280446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (268.69 - 287.33) | Buy |
| Bollinger Bands (100): | (203.01 - 287.97) | Buy |
MPC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160 | Sell |
| 20-day SMA: | 163.4 | Sell |
| 50-day SMA: | 167.31 | Sell |
| 200-day SMA: | 174.78 | Sell |
| 8-day EMA: | 159.75 | Sell |
| 20-day EMA: | 162.46 | Sell |
| 50-day EMA: | 165.78 | Sell |
| 200-day EMA: | 167.47 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 289.83 | Buy |
| 20-day SMA: | 279.03 | Buy |
| 50-day SMA: | 272.38 | Buy |
| 200-day SMA: | 202.09 | Buy |
| 8-day EMA: | 289.74 | Buy |
| 20-day EMA: | 281.65 | Buy |
| 50-day EMA: | 269.29 | Buy |
| 200-day EMA: | 222.03 | Buy |
Marathon Petroleum Earnings Growth & MPC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $12.91 per share, and an increase next year of $1.34 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.75 per share.
Marathon Petroleum Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||